Skip to main content
SAMJIN PHARMACEUTICAL CO.,LTD logo

SAMJIN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 005500 ISIN · KR7005500004 KO Manufacturing
Open in API
Filings indexed 253 across all filing types
Latest filing 2026-05-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 005500

About SAMJIN PHARMACEUTICAL CO.,LTD

https://www.samjinpharm.co.kr/

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is the Korean statutory “주식등의 대량보유상황보고서(약식)” (Report on Large Shareholding Status), filed under the Capital Markets Act. It details shareholding amounts, percentages, changes, and reasons by a major shareholder. This clearly matches the “Major Shareholding Notification” category.
2026-05-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” which translates to a report on an executive’s holdings and changes in specific securities. It’s filed with the Financial Services Commission and Korea Exchange, details an officer’s shareholdings, changes, and transaction dates. This clearly aligns with a director’s dealings/insider transaction report (DIRS), rather than a general announcement or major shareholding notification. Therefore, the correct classification is DIRS.
2026-05-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 94% confidence The document is a regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s shareholdings and recent trades (dates, amounts, transaction types). It is a classic insider share ownership and transaction report by a director/senior manager. This matches the ‘Director’s Dealing’ category (insider transactions by company executives).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제59기) 2026년 01월 01일–2026년 03월 31일” and contains comprehensive quarterly financial statements, notes, business overview, management’s analysis, audit opinion, and other mandatory sections. It is a full interim/quarterly report rather than a brief announcement or transcript. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a mandatory regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” filed with the Securities and Futures Commission and Korea Exchange. It details the shareholding status and transactions (acquisition/disposal) of a company executive (Park Chang Ik). This matches the definition of an insider share transaction report by directors/executives. Therefore, it should be classified as Director’s Dealing (DIRS).
2026-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a Korean-language notice titled “정기주주총회 결과” (Regular General Shareholders’ Meeting Results) dated 2026.03.24. It lists each AGM agenda item, vote outcomes (approval status and vote percentages), elected directors, dividend approvals, and related resolutions. This format matches the Declaration of Voting Results & Voting Rights Announcements category, as it provides official shareholder vote results from a general meeting.
2026-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.